a biopharmaceutical company that is engaged in developing compounds for the treatment and imaging of cancer
Industry Biotechnology
A.I.dvisor indicates that over the last year, CLRB has been loosely correlated with CELC. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if CLRB jumps, then CELC could also see price increases.
Ticker / NAME | Correlation To CLRB | 1D Price Change % | ||
---|---|---|---|---|
CLRB | 100% | -3.83% | ||
CELC - CLRB | 35% Loosely correlated | -3.62% | ||
SNDX - CLRB | 33% Loosely correlated | +0.96% | ||
ARDX - CLRB | 33% Loosely correlated | +4.67% | ||
CRNX - CLRB | 33% Poorly correlated | +1.26% | ||
XFOR - CLRB | 31% Poorly correlated | +47.85% | ||
More |
Ticker / NAME | Correlation To CLRB | 1D Price Change % |
---|---|---|
CLRB | 100% | -3.83% |
cancer theme (82 stocks) | 39% Loosely correlated | -2.35% |
treatment theme (56 stocks) | 36% Loosely correlated | -1.02% |
biopharmaceuticals theme (50 stocks) | 35% Loosely correlated | -2.60% |
drugs theme (254 stocks) | 34% Loosely correlated | -1.67% |
biotechnology theme (238 stocks) | 17% Poorly correlated | -1.76% |